Keith Loria is a contributing writer to Medical Economics.
Immune Checkpoint Inhibitors Study for People Living With HIV Shows Promising Results
June 22nd 2023Researchers and clinicians have been wary of treating people living with HIV with Keytruda, Opdivo and other immune checkpoint inhibitors because removing an inhibitory step in the immune response was seen as risky for people with compromised immune systems.
Read More
Examining Adverse Pregnancy Outcomes in People Living with HIV
March 21st 2023The known benefits of antiretroviral therapy (ART) in pregnant persons living with HIV outweigh the risks, which include low-birth weight and metabolic complications for the pregnant person, says the lead author of a review article ART and adverse outcomes published in the New England Journal of Medicine.
Read More